BR9610983A - Formas estáveis de administração farmacêuticas contendo paratormônio - Google Patents

Formas estáveis de administração farmacêuticas contendo paratormônio

Info

Publication number
BR9610983A
BR9610983A BR9610983A BR9610983A BR9610983A BR 9610983 A BR9610983 A BR 9610983A BR 9610983 A BR9610983 A BR 9610983A BR 9610983 A BR9610983 A BR 9610983A BR 9610983 A BR9610983 A BR 9610983A
Authority
BR
Brazil
Prior art keywords
parathormone
pharmaceutical administration
administration containing
stable forms
stable
Prior art date
Application number
BR9610983A
Other languages
English (en)
Portuguese (pt)
Inventor
Hendrik Von Bueren
Rolf-Dieter Gabel
Wolfgang Roedel
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of BR9610983A publication Critical patent/BR9610983A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9610983A 1995-10-17 1996-10-17 Formas estáveis de administração farmacêuticas contendo paratormônio BR9610983A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19538687A DE19538687A1 (de) 1995-10-17 1995-10-17 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
PCT/EP1996/004503 WO1997014429A1 (de) 1995-10-17 1996-10-17 Stabile pharmazeutische darreichungsformen enthaltend parathormon

Publications (1)

Publication Number Publication Date
BR9610983A true BR9610983A (pt) 1999-03-02

Family

ID=7775105

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610983A BR9610983A (pt) 1995-10-17 1996-10-17 Formas estáveis de administração farmacêuticas contendo paratormônio

Country Status (14)

Country Link
EP (1) EP0855917A1 (cs)
JP (1) JPH11515002A (cs)
KR (1) KR19990064322A (cs)
AU (1) AU7294196A (cs)
BR (1) BR9610983A (cs)
CA (1) CA2234724A1 (cs)
CZ (1) CZ108398A3 (cs)
DE (1) DE19538687A1 (cs)
HU (1) HUP9900751A3 (cs)
NZ (1) NZ320237A (cs)
SK (1) SK47298A3 (cs)
TR (1) TR199800690T1 (cs)
WO (1) WO1997014429A1 (cs)
ZA (1) ZA968715B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
DE19716154A1 (de) * 1997-04-18 1998-10-22 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren
ZA9811127B (en) 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
WO2001032201A2 (en) * 1999-10-29 2001-05-10 Eli Lilly And Company A pharmaceutical composition having high cell membrane permeability
JP2003522154A (ja) * 2000-02-08 2003-07-22 アラーガン、インコーポレイテッド ボツリヌス毒素医薬組成物
AR032461A1 (es) * 2000-06-30 2003-11-12 Daiichi Asubio Pharma Co Ltd Componente farmaceutico que comprende un peptido de la hormona paratiroidea humana o su derivado y acido acetico, composicion farmaceutica para la administracion intranasal que comprende dicho componente, y producto farmaceutico que comprende dicho componente
CA2517310C (en) * 2003-02-28 2015-11-24 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations comprising a poloxamer
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
KR100700869B1 (ko) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2947181B1 (fr) * 2009-06-26 2012-05-04 Lfb Biotechnologies Composition de facteur vii
KR101787956B1 (ko) 2011-06-07 2017-10-18 아사히 가세이 파마 가부시키가이샤 고순도 pth 함유 동결 건조 제제 및 그의 제조 방법
RS67458B1 (sr) 2014-03-28 2025-12-31 Univ Duke Lečenje kancera dojke pozitivnog na receptor estrogena upotrebom selektivnih modulatora receptora estrogena
KR102676629B1 (ko) 2015-04-29 2024-06-18 래디어스 파마슈티컬스, 인코포레이티드 암을 치료하는 방법
JP6634758B2 (ja) * 2015-09-25 2020-01-22 ニプロ株式会社 液体組成物及び凍結乾燥製剤
KR102881465B1 (ko) 2017-01-05 2025-11-04 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
US20200289621A1 (en) * 2017-09-22 2020-09-17 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent stability
CN112423844B (zh) 2018-07-04 2024-08-13 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
JOP20210218A1 (ar) 2019-02-12 2023-01-30 Radius Pharmaceuticals Inc عمليات ومركبات
WO2021229835A1 (ja) * 2020-05-11 2021-11-18 旭化成ファーマ株式会社 テリパラチド又はその塩を含有する安定な液状医薬製剤
JP6947946B1 (ja) * 2020-05-11 2021-10-13 旭化成ファーマ株式会社 テリパラチド又はその塩を含有する安定な液状医薬製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
JP2739482B2 (ja) * 1988-08-11 1998-04-15 バイオ・チバ株式会社 安定なカルシトニン注射液の製造方法
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
DE4203040A1 (de) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
HUP9900751A2 (hu) 1999-07-28
SK47298A3 (en) 1998-11-04
DE19538687A1 (de) 1997-04-24
CA2234724A1 (en) 1997-04-24
ZA968715B (en) 1998-04-16
NZ320237A (en) 1999-11-29
CZ108398A3 (cs) 1998-09-16
AU7294196A (en) 1997-05-07
KR19990064322A (ko) 1999-07-26
EP0855917A1 (de) 1998-08-05
JPH11515002A (ja) 1999-12-21
TR199800690T1 (xx) 1998-06-22
HUP9900751A3 (en) 2000-07-28
WO1997014429A1 (de) 1997-04-24

Similar Documents

Publication Publication Date Title
NO981073L (no) Farmasöytiske formuleringer inneholdende darifenacin
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
PT843676E (pt) Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongada
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
FI955091L (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
KR950700754A (ko) 신규의 약물(novel medicament)
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
BR9611626A (pt) Formulações farmacéuticas
KR970000221A (ko) 약물 및 화장품의 국소 전달을 위한 트리코-형 파우치
DE69632533D1 (de) Intrapulmonare verabreichung vom hematopoietischem medikament
NO981008D0 (no) Farmasöytisk formulering
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
EP0823255A4 (en) Pharmaceutical composition containing sucralfate
FI964619A7 (fi) Epilepsialääkkeiden iholle annostelu
ATE256465T1 (de) Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form
FI973230A7 (fi) Uusi farmaseuttinen formulaatio
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
NO951933L (no) Farmasöytiske formuleringer av ibuprofen
BR9606066A (pt) Composto e formulação farmacêutica
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai

Legal Events

Date Code Title Description
TC Change of name
FA10 Dismissal: dismissal - article 33 of industrial property law